Glucophage SR
In brief
- Glucophage SR: under this name we supply metformin prolonged-release 1000 mg tablets (Glycomet SR), in packs of 60 or 90. Metformin is a prescription-only medicine in the UK.
- This drug treats type 2 diabetes by decreasing liver glucose production, reducing intestinal sugar absorption, and improving insulin sensitivity, as classified under ATC code A10BA02 for biguanides.
- The 1000 mg prolonged-release strength is intended for patients already taking metformin; the prescriber sets the dose. Starting treatment or making smaller dose adjustments requires another strength, which is not offered here.
- It is administered orally as extended-release tablets, designed for once-daily intake without crushing or splitting.
- Blood glucose response is assessed after about 10–15 days when adjusting treatment.
- The prolonged-release formulation is usually taken once daily with the evening meal, as prescribed.
- Avoid excessive alcohol consumption, as it increases the risk of lactic acidosis, a potentially fatal side effect. Metformin is not metabolised and is eliminated through the kidneys.
- The most common side effects are gastrointestinal (nausea, diarrhoea, abdominal pain), which are typically mild and transient, improving with gradual dose titration.
- Use metformin only as prescribed.
Basic Glucophage SR information
| INN | Metformin hydrochloride |
| UK brand names | Glucophage SR |
| ATC Code | A10BA02 |
| Form & strength | Metformin prolonged-release tablets, 1000 mg only (Glycomet SR); packs of 60 or 90 |
| Manufacturer | Refer to the supplied Glycomet SR pack for manufacturer details |
| Registration status | The UK licence for Glucophage SR does not establish UK authorisation of the supplied Glycomet SR pack |
| Classification | Prescription-only medicine (POM) |
Under the name Glucophage SR we supply metformin prolonged-release 1000 mg tablets (Glycomet SR), in packs of 60 or 90. No other strengths are offered here. Metformin is a prescription-only medicine in the United Kingdom.
Mechanism of action and pharmacodynamics
Glucophage SR works through dual mechanisms to regulate blood sugar levels without increasing insulin production:
- Reduces hepatic glucose production: Metformin decreases gluconeogenesis (new glucose formation) in liver cells
- Enhances insulin sensitivity: Improves peripheral glucose uptake and utilisation in muscle and fat tissue
Unlike immediate-release formulations, Glucophage SR tablets feature specialised slow-release technology. Hydrophilic polymer matrices in the tablet core gradually absorb water, swelling to form a gel barrier that controls metformin dissolution over 8-10 hours. This extended-release design modulates drug delivery, maintaining steadier plasma concentrations while lowering peak drug levels. Pharmacodynamic effects include suppressed fasting and post-meal glucose values primarily through AMPK activation pathways, with negligible hypoglycaemia risk versus insulin secretagogues.
Approved indications and off-label use
Glucophage SR is licensed in the UK for type 2 diabetes management alongside diet and exercise. Within NHS diabetes pathways, it serves as first-line therapy both as monotherapy and in combination regimens.
Under specialist guidance, evidence supports several off-label applications:
- Polycystic ovary syndrome (PCOS) - improves insulin resistance and ovulation frequency
- Prediabetes management - reduces progression to diabetes in high-risk individuals
- Antipsychotic-induced weight gain mitigation
Important UK-specific protocols exist for:
- Elderly patients: Intensive renal monitoring required before initiation
- Pregnancy: Continued under specialist supervision only
- Children and adolescents: The UK SmPC does not recommend prolonged-release metformin in this age group because of insufficient data
Prescribing follows practitioners' clinical judgement after evaluating benefit-risk profiles through NHS diabetes teams.
Standard dosage protocols
| Condition | Initial dose | Maintenance dose | Timing |
|---|---|---|---|
| Type 2 diabetes | 1000 mg strength for patients already taking metformin; starting treatment requires another strength | Individualised by the prescriber, up to 2000 mg daily where appropriate | With evening meal |
| PCOS | Off-label use requires specialist advice; only 1000 mg tablets are offered here | Individualised by the specialist; other strengths may be needed | With a meal |
The 1000 mg prolonged-release strength is intended for patients already taking metformin. Dose adjustments are assessed after 10–15 days using blood glucose measurements and tolerability; smaller adjustments require another strength, not offered here. Renal function also limits the dose:
- eGFR 45-59 mL/min: Maximum 2000 mg daily
- eGFR 30-44 mL/min: Maximum 1000 mg daily
- eGFR under 30 mL/min: Contraindicated
Tablets must be swallowed whole with fluid during meals, never crushed or split. Glucophage SR is usually taken once daily with the evening meal. Consistently taking Glucophage SR with food minimises gastrointestinal side effects.
Contraindications & safety warnings
Glucophage SR carries several important safety restrictions. Most critically, this medication is absolutely contraindicated for patients with renal impairment (eGFR below 30 mL/min/1.73m²) or those experiencing metabolic acidosis conditions like diabetic ketoacidosis. It should also not be used in patients with severe liver disease, alcoholism, or conditions causing tissue hypoxia, such as acute or unstable heart failure. Stable chronic heart failure requires regular cardiac and renal monitoring.
Lactic acidosis is a rare but life-threatening complication requiring urgent hospital treatment. Patients should know its early warning signs: unexplained muscle pain, rapid breathing, extreme fatigue, or abdominal discomfort, especially during heatwaves when dehydration risks increase.
Common side effects, especially at the start of treatment, are mainly gastrointestinal and include:
- Nausea
- Diarrhoea
- Abdominal discomfort
Other effects include a metallic taste and, with long-term use, vitamin B12 deficiency. Most GI symptoms diminish within weeks when taken correctly with evening meals. Alcohol avoidance remains crucial due to heightened lactate production risks.
Therapeutic alternatives comparison
Glucophage SR compares distinctly against other UK diabetes medications:
| Medication (formulation) | Hypoglycaemia risk | NICE recommendation |
|---|---|---|
| Glucophage SR (prolonged release) | Low | First-line monotherapy |
| Gliclazide (immediate release) | High | Second-line option |
| Dapagliflozin (SGLT2 inhibitor) | Low | Combination therapy |
| Insulin glargine | High | Advanced treatment |
As NICE guidelines emphasise, metformin remains first-line therapy (modified-release if the standard form is not tolerated) due to favourable cardiovascular safety and minimal hypoglycaemia risk. Gliclazide becomes appropriate when metformin isn't tolerated but carries weight gain and hypos risks. Newer agents like SGLT2 inhibitors (dapagliflozin) bring specific kidney and heart benefits in complex cases requiring multidisciplinary diabetes team management.
Common Glucophage SR questions
Patients managing diabetes with Glucophage SR often have specific questions relevant to daily life in the UK. Here are answers to some frequent queries based on NHS guidance and Diabetes UK resources:
Can I take Glucophage SR during Ramadan? Managing medication during fasting periods requires careful planning. The NHS advises consulting a diabetes nurse or doctor well before Ramadan. The timing of the prescribed dose during Ramadan should be agreed with your diabetes team. Never alter your dose or timing without professional advice.
Does metformin SR cause weight gain? A key advantage of metformin SR is its weight profile. Unlike insulin or sulfonylureas (such as gliclazide), which are commonly associated with weight gain, metformin, including the SR form, is generally weight-neutral. Some individuals may even experience modest weight loss, particularly at the start of treatment, due to reduced appetite.
What should I do if I miss a dose of Glucophage SR? Skip the missed dose and take the next dose at the usual time. Never double-dose to make up for a forgotten tablet. Taking two doses close together significantly increases the risk of side effects.
Is it okay to drink alcohol with Glucophage SR? Excessive alcohol intake is strongly discouraged for several reasons. It can increase the risk of a rare but serious side effect called lactic acidosis and also negatively impact blood sugar control. NHS guidance recommends discussing safe alcohol limits with your healthcare team if you choose to drink.
Guidelines for taking and storing Glucophage SR
Using Glucophage SR correctly maximises its effectiveness and minimises potential side effects. Follow these practical NHS-aligned guidelines:
- Taking your dose: Always swallow Glucophage SR tablets whole with a drink of water. Never crush or chew them – this damages the extended-release mechanism, potentially releasing all the medicine at once and increasing side effects. Take your daily dose with or just after your evening meal to reduce gastrointestinal upset like nausea or stomach ache.
- Lifestyle factors: Avoid excessive alcohol consumption. Be mindful of your hydration, especially during hot weather or exercise, as dehydration can affect kidney function. Regular physical activity complements the medicine's effect on blood sugar control.
- Storage: Keep Glucophage SR in its original blister pack or container. Store it below 25°C, in a cool, dry place. Keep it out of sight and reach of children. Avoid storing it in bathrooms or near sinks due to moisture. Discard any tablets that are discoloured, damaged, or look different from usual.
- Avoiding common mistakes: Skipping doses regularly makes blood sugar control much harder. Doubling up a dose because you forgot earlier significantly increases the chance of nausea, diarrhoea, and rarely, more serious issues. Stick to your prescribed schedule.
Glucophage SR drug interactions
While generally well-tolerated, Glucophage SR (metformin SR) can interact with certain other medicines. Always inform your doctor and pharmacist about everything you take. Some significant interactions include:
High-risk interactions
Avoid combining with these:
| Interacting substance | Risk level | Management |
|---|---|---|
| Contrast dye (iodinated) used in X-ray/CT scans | High | Must pause Glucophage SR at the time of or before the scan and not restart until at least 48 hours afterwards, once kidney function is confirmed stable |
Moderate risk interactions
Use with caution and monitor:
| Beta-blockers (e.g., propranolol, atenolol for blood pressure/angina) | Moderate | Can sometimes mask low blood sugar symptoms and potentially affect glucose control; need careful monitoring |
| Diuretics ('water tablets' like furosemide or bendroflumethiazide) | Moderate | Can affect kidney function and fluid balance, increasing risks; kidney function checks are essential |
Low risk interactions
Typically no adjustment needed:
| ACE inhibitors (e.g., ramipril, lisinopril for blood pressure/heart failure) | Low | No specific metformin dose adjustment usually required |
Always discuss potential drug interactions with your GP or pharmacist before taking Glucophage SR with other medications, especially before scans with iodinated contrast dye.